Cellular Biomedicine Inc logo

CBMG - Cellular Biomedicine Inc News Story

$18.11 0.2  1.3%

Last Trade - 15/01/21

Sector
Healthcare
Size
Small Cap
Market Cap £259.6m
Enterprise Value £275.7m
Revenue £238k
Position in Universe 3633rd / 6547

BRIEF-Sailing Capital Overseas Investments Fund Reports 8.9% Stake In Cellular Biomedicine Group As Of Feb 21

Fri 21st February, 2020 11:23pm
Feb 21 (Reuters) - Sailing Capital Overseas Investments
Fund:  
    * SAILING CAPITAL OVERSEAS INVESTMENTS FUND REPORTS 8.9%
STAKE IN
CELLULAR BIOMEDICINE GROUP AS OF FEB 21 - SEC FILING
    * SAILING CAPITAL OVERSEAS INVESTMENTS FUND HAD EARLIER
REPORTED A
10.1% STAKE IN CELLULAR BIOMEDICINE GROUP AS OF FEB 5, 2018 -
SEC FILING
    * SAILING CAPITAL OVERSEAS-ON FEB 21, BUYER CONSORTIUM
(INCLUDING
INITIAL, ADDITIONAL CONSORTIUM MEMBERS) SUBMITTED NEW PROPOSAL
TO CELLULAR BIOMEDICINE'S SPECIAL COMMITTEE
    * SAILING CAPITAL OVERSEAS-BUYER CONSORTIUM PROPOSED TO
ACQUIRE
ALL OF CELLULAR BIOMEDICINE'S OUTSTANDING SHARES (OTHER THAN
ROLLOVER SHARES) FOR $19.50 PER SHARE IN CASH

Source text: (https://bit.ly/2wCtWfH)
Further company coverage:  CBMG.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.